DK248783A - Fremgangsmaade til fremstilling af en sammensaetning til topisk indgivelse - Google Patents

Fremgangsmaade til fremstilling af en sammensaetning til topisk indgivelse Download PDF

Info

Publication number
DK248783A
DK248783A DK248783A DK248783A DK248783A DK 248783 A DK248783 A DK 248783A DK 248783 A DK248783 A DK 248783A DK 248783 A DK248783 A DK 248783A DK 248783 A DK248783 A DK 248783A
Authority
DK
Denmark
Prior art keywords
submission
topical
preparing
procedure
composition
Prior art date
Application number
DK248783A
Other languages
Danish (da)
English (en)
Other versions
DK248783D0 (da
Inventor
Eugene Rex Cooper
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of DK248783D0 publication Critical patent/DK248783D0/da
Publication of DK248783A publication Critical patent/DK248783A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK248783A 1982-06-01 1983-06-01 Fremgangsmaade til fremstilling af en sammensaetning til topisk indgivelse DK248783A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38389182A 1982-06-01 1982-06-01
US48966383A 1983-05-06 1983-05-06

Publications (2)

Publication Number Publication Date
DK248783D0 DK248783D0 (da) 1983-06-01
DK248783A true DK248783A (da) 1983-12-02

Family

ID=27010375

Family Applications (1)

Application Number Title Priority Date Filing Date
DK248783A DK248783A (da) 1982-06-01 1983-06-01 Fremgangsmaade til fremstilling af en sammensaetning til topisk indgivelse

Country Status (6)

Country Link
EP (1) EP0095813A3 (cs)
AU (1) AU1527983A (cs)
CA (1) CA1200497A (cs)
DK (1) DK248783A (cs)
GR (1) GR79207B (cs)
PT (1) PT76780A (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
EP0190123A1 (en) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Immunoregulatory and anti-viral compound
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
LU86393A1 (fr) * 1986-04-16 1987-12-07 Oreal Composition anti-acneique stable a base d'erythromycine
ES2042564T3 (es) * 1986-06-13 1993-12-16 Procter & Gamble Composiciones por via topica penetrantes mejoradas para aumentar el crecimiento del cabello.
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
EP0267617B1 (en) * 1986-11-14 1992-06-24 Theratech, Inc. Penetration enhancement with binary system of cell envelope disordering compounds and lower alcohols
EP0302147A1 (en) * 1987-08-03 1989-02-08 The Procter & Gamble Company Topical tanning compositions
EP0351897A3 (en) * 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
AU701574B2 (en) * 1993-05-12 1999-02-04 Karl Y. Hostetler Acyclovir derivatives for topical use
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
DE19624508A1 (de) * 1996-06-19 1998-01-08 Guetter Hans Peter Dr Verwendung von C¶3¶-C¶4¶-Alkoholen zur Behandlung von Herpeserkrankungen
GB9618974D0 (en) * 1996-09-11 1996-10-23 Glaxo Group Ltd Medicaments
AU5460800A (en) * 1999-06-02 2000-12-18 Aviana Biopharm Pharmaceutical transdermal compositions
WO2010008600A1 (en) * 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
DK154561C (da) * 1981-08-11 1989-04-24 Wellcome Found Analogifremgangsmaade til fremstilling af antivirale 9-substituerede 2-aminopurinderivater eller fysiologisk acceptable salte eller estere deraf

Also Published As

Publication number Publication date
DK248783D0 (da) 1983-06-01
CA1200497A (en) 1986-02-11
GR79207B (cs) 1984-10-22
PT76780A (en) 1983-06-01
AU1527983A (en) 1983-12-08
EP0095813A2 (en) 1983-12-07
EP0095813A3 (en) 1985-05-08

Similar Documents

Publication Publication Date Title
DK248783A (da) Fremgangsmaade til fremstilling af en sammensaetning til topisk indgivelse
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK156283D0 (da) Fremgangsmade til fremstilling af fedt-glykosid-blandinger
DK158282C (da) Fremgangsmaade til fremstilling af et fast fibrinogenpraeparat
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK520580A (da) Fremgangsmaade til fremstilling af en pakning
DK158048C (da) Fremgangsmaade til forstaerkning af en partikelformet grundmasse
DK228080A (da) Fremgangsmaade til fremstilling af saccharosemonoestere
DK1584A (da) Fremgangsmaade til fremstilling af et gitterkernesandwichelement
DK468183D0 (da) Fremgangsmade til fremstilling af aminoglycosidderivater
DK299483D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK211783A (da) Fremgangsmaade til fremstilling af pyrazolpyridinforbindelser
DK283083A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK119083A (da) Fremgangsmaade til fremstilling af alkanoylpyridinoner
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
DK529181A (da) Fremgangsmaade til fremstilling af substituerede benzamider
DK394783A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK399783D0 (da) Fremgangsmade til fremstilling af substituerede 1-puridyloxy-3-indolylalkylamino-2-propanoler
MX158241A (es) Mejoras a composicion dentifrica
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer
DK299083D0 (da) Fremgangsmade til fremstilling af cephalosporinforbindelser
DK223683D0 (da) Fremgangsmade til fremstilling af dihydropyridiner
DK193983D0 (da) Fremgangsmade til fremstilling af substituerede phenylendiaminer
DK9383D0 (da) Fremgangsmade til fremstilling af phosphinoxider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment